Mastercard (MA) buy case: low odds of rate caps/CCCA, limited revenue/EPS exposure, strong moat and growth from cross-border ...

Carl Zeiss Meditec AG is rated Strong Buy with higher share price target, undervaluation & robust fundamentals. Read more on ...